Daily Screen Time Tied to Higher Myopia Risk
By Lori Solomon HealthDay Reporter
TUESDAY, Feb. 25, 2025 -- The risk for myopia increases significantly with one to four hours of daily exposure to screen time, according to a review published online Feb. 21 in JAMA Network Open.
Ahnul Ha, M.D., from Jeju National University Hospital in Jeju-si, South Korea, and colleagues conducted a systematic literature review to characterize the association between digital screen time and myopia risk.
Based on 45 studies (335,524 participants), a linear random-effects, dose-response meta-analysis (DRMA) showed an additional hour of daily screen time was associated with higher odds of myopia (odds ratio, 1.21). The nonlinear DRMA among 34 studies (314,910 participants) also indicated higher odds of myopia with increasing screen time, ranging from one hour of daily exposure (odds ratio, 1.05) to four hours of daily exposure (odds ratio, 1.97). Myopia risk increased significantly between one to four hours of daily screen time in a dose-response curve, and then rose more gradually after four hours.
"These findings can offer guidance for clinicians and researchers and underscore the need to refine dose-response models for digital screen time and myopia risk to better address the myopia pandemic," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-02-26 06:00
Read more

- Flu and Stomach Bugs Are Spreading Fast—Are You Prepared?
- Boston Surgeons Successfully Transplant Pig Kidney in Fourth Patient
- Ozempic-Type Drug Fails To Slow Parkinson’s, Study Finds
- Black Patients With Cancer Still Have Higher Mortality Rates Than Whites
- Rapid Blood Test Can Improve Stroke Treatment
- Daily Aspirin Reduces Colon Cancer Risk: Study
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions